189 related articles for article (PubMed ID: 29174585)
1. Current Trends and Future Perspectives in the Treatment of Pulmonary Arterial Hypertension.
Bhogal S; Mukherjee D; Banerjee S; Tan W; Paul TK
Curr Probl Cardiol; 2018 May; 43(5):191-216. PubMed ID: 29174585
[TBL] [Abstract][Full Text] [Related]
2. Current Trends and Future Perspectives in the Treatment of Pulmonary Hypertension: WHO Group II-V.
Bhogal S; Mukherjee D; Banerjee S; Islam AM; Daggubati R; Paul TK
Curr Probl Cardiol; 2018 May; 43(5):217-231. PubMed ID: 29153390
[TBL] [Abstract][Full Text] [Related]
3. Management of Pulmonary Hypertension: Associated with Left Heart Disease.
Franco V
Heart Fail Clin; 2018 Oct; 14(4):545-551. PubMed ID: 30266363
[TBL] [Abstract][Full Text] [Related]
4. Compelling evidence of long-term outcomes in pulmonary arterial hypertension? A clinical perspective.
Gomberg-Maitland M; Dufton C; Oudiz RJ; Benza RL
J Am Coll Cardiol; 2011 Mar; 57(9):1053-61. PubMed ID: 21349396
[TBL] [Abstract][Full Text] [Related]
5. Repurposing Medications for Treatment of Pulmonary Arterial Hypertension: What's Old Is New Again.
Prins KW; Thenappan T; Weir EK; Kalra R; Pritzker M; Archer SL
J Am Heart Assoc; 2019 Jan; 8(1):e011343. PubMed ID: 30590974
[No Abstract] [Full Text] [Related]
6. Pulmonary arterial hypertension: evaluation and management.
LaRaia AV; Waxman AB
South Med J; 2007 Apr; 100(4):393-9. PubMed ID: 17458400
[TBL] [Abstract][Full Text] [Related]
7. Borderline pulmonary pressures in scleroderma - a 'pre-pulmonary arterial hypertension' condition?
Kovacs G; Olschewski H
Arthritis Res Ther; 2015 May; 17(1):123. PubMed ID: 25981512
[TBL] [Abstract][Full Text] [Related]
8. Current pathophysiological concepts and management of pulmonary hypertension.
Lourenço AP; Fontoura D; Henriques-Coelho T; Leite-Moreira AF
Int J Cardiol; 2012 Mar; 155(3):350-61. PubMed ID: 21641060
[TBL] [Abstract][Full Text] [Related]
9. World Health Organization Group I Pulmonary Hypertension: Epidemiology and Pathophysiology.
Prins KW; Thenappan T
Cardiol Clin; 2016 Aug; 34(3):363-74. PubMed ID: 27443134
[TBL] [Abstract][Full Text] [Related]
10. Safety, efficacy, and clinical utility of macitentan in the treatment of pulmonary arterial hypertension.
Monaco TJ; Davila CD
Drug Des Devel Ther; 2016; 10():1675-82. PubMed ID: 27274200
[TBL] [Abstract][Full Text] [Related]
11. Treatment initiation in paediatric pulmonary hypertension: insights from a multinational registry.
Humpl T; Berger RMF; Austin ED; Fasnacht Boillat MS; Bonnet D; Ivy DD; Zuk M; Beghetti M; Schulze-Neick I
Cardiol Young; 2017 Aug; 27(6):1123-1132. PubMed ID: 27995825
[TBL] [Abstract][Full Text] [Related]
12. [Current approach to the treatment of pulmonary arterial hypertension and our experience in the Cardiology Department of Medicine Faculty of Ege University].
Kayikçioğlu M; Kültürsay H
Turk Kardiyol Dern Ars; 2009 Dec; 37(8):580-90. PubMed ID: 20200464
[TBL] [Abstract][Full Text] [Related]
13. A review of therapeutic agents for the management of pulmonary arterial hypertension.
Hahn SS; Makaryus M; Talwar A; Narasimhan M; Zaidi G
Ther Adv Respir Dis; 2017 Jan; 11(1):46-63. PubMed ID: 27595643
[TBL] [Abstract][Full Text] [Related]
14. Pediatric pulmonary arterial hypertension--a review.
Ferns SJ; Wehrmacher WH; Serratto M
Compr Ther; 2009; 35(2):81-90. PubMed ID: 19618756
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary arterial hypertension: a current review of pharmacological management.
Sahni S; Ojrzanowski M; Majewski S; Talwar A
Pneumonol Alergol Pol; 2016; 84(1):47-61. PubMed ID: 26693827
[TBL] [Abstract][Full Text] [Related]
16. Looking to the future: a new decade of pulmonary arterial hypertension therapy.
McLaughlin VV
Eur Respir Rev; 2011 Dec; 20(122):262-9. PubMed ID: 22130819
[TBL] [Abstract][Full Text] [Related]
17. Monocrotaline-induced pulmonary hypertension in Wistar rats.
Rey M; Hess P; Clozel M
Curr Protoc Pharmacol; 2009 Sep; Chapter 5():Unit 5.56. PubMed ID: 22294402
[TBL] [Abstract][Full Text] [Related]
18. Correlation between right ventricular indices and clinical improvement in epoprostenol treated pulmonary hypertension patients.
Nath J; Demarco T; Hourigan L; Heidenreich PA; Foster E
Echocardiography; 2005 May; 22(5):374-9. PubMed ID: 15901287
[TBL] [Abstract][Full Text] [Related]
19. Building the case for novel clinical trials in pulmonary arterial hypertension.
Ryan JJ; Rich JD; Maron BA
Circ Cardiovasc Qual Outcomes; 2015 Jan; 8(1):114-23. PubMed ID: 25604559
[No Abstract] [Full Text] [Related]
20. Ventricular Diastolic Pressure Ratio as a Marker of Treatment Response in Pulmonary Hypertension.
Jose A; King CS; Shlobin OA; Kiernan JM; Cossa NA; Brown AW; Nathan SD
Chest; 2017 Nov; 152(5):980-989. PubMed ID: 28527879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
